| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RNA | Common Stock | Options Exercise | $828,900 | +30,000 | $27.63 | 30,000 | 07 Oct 2024 | Direct | ||
| transaction | RNA | Common Stock | Sale | $1,349,259 | -30,000 | -100% | $44.98 | 0 | 07 Oct 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RNA | Stock Option (Right to Buy) | Options Exercise | $0 | -30,000 | -100% | $0.000000 | 0 | 07 Oct 2024 | Common Stock | 30,000 | $27.63 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.20 to $45.57. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | The option was granted on January 11, 2021 and fully vested prior to the date of transactions described in this form. |